Global Autologous Matrix-Induced Chondrogenesis (AMIC) Strategic Industry Report, 2022-2024 and 2030 - U.S. Market is Estimated at $49.5 Million, While China is Forecast to Grow at 9.8% CAGR
Wednesday, March 6, 2024
DUBLIN, Feb. 27, 2024 /PRNewswire/ -- The "Autologous Matrix-Induced Chondrogenesis (AMIC) - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
Global Autologous Matrix-Induced Chondrogenesis (AMIC) Market to Reach $278 Million by 2030
The global market for Autologous Matrix-Induced Chondrogenesis (AMIC) estimated at US$153 Million in the year 2022, is projected to reach a revised size of US$278 Million by 2030, growing at a CAGR of 7.7% over the analysis period 2022-2030. Collagen, one of the segments analyzed in the report, is projected to record a 7.5% CAGR and reach US$158.8 Million by the end of the analysis period. Growth in the Hyaluronic Acid segment is estimated at 6.9% CAGR for the next 8-year period.
The Autologous Matrix-Induced Chondrogenesis (AMIC) market is poised for growth due to the increasing prevalence of joint disorders. Despite a global economic update, the pandemic has cast a shadow over the normalcy of orthopedic surgery volumes. The market share of key competitors in the AMIC sector in 2023 reflects a competitive landscape, with various players exhibiting strong, active, niche, or trivial market presence. Recent market activity underscores ongoing developments and adaptations within the AMIC market to address evolving needs and challenges in orthopedic care.
The U.S. Market is Estimated at $49.5 Million, While China is Forecast to Grow at 9.8% CAGR
The Autologous Matrix-Induced Chondrogenesis (AMIC) market in the U.S. is estimated at US$49.5 Million in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$26.1 Million by the year 2030 trailing a CAGR of 9.8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.4% and 7.3% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 8.1% CAGR.
MARKET TRENDS & DRIVERS
-- AMIC Holds Significance in Cartilage Repair Domain
-- Rise in Sports Participation and Increase in Sports-Related Injuries
Augment Growth Prospects
-- Autologous Matrix-Induced Chondrogenesis (AMIC) in Ankle Repair: A
Review
-- Growing Demand for Minimally-Invasive Surgeries to Propel Market Growth
-- Rise in Incidence of Osteoporosis to Benefit Market Growth
-- AMIC: Highly Effective in Management of Focal Chondral Defects of the
Knee
-- Assessment of Open & Arthroscopic Approaches for AMIC to Repair
Cartilage Defects
-- Cellular Therapy as Lifeblood of Clinical Routines Targeting Cartilage
Regeneration
-- MACI Solutions: Promising Options in Articular Cartilage Treatment
-- Aging Population and their Vulnerability to Various Bone and Joint
Related Diseases and Disorders Drive Healthy Market Growth
-- Rise in Overweight Patients to Boost Prospects
-- Changing Lifestyle Impacting Bone Health
-- Rising Healthcare Spending Augurs Well for the Market
FOCUS ON SELECT PLAYERS(Total 28 Featured)
-- Anika Therapeutics, Inc.
-- Arthro Kinetics AG
-- B. Braun Melsungen AG
-- BioTissue SA
-- CartiHeal, Inc.
-- Geistlich Pharma AG
-- JRI Orthopaedics Ltd.
-- Matricel GmbH
-- Smith & Nephew PLC
-- Zimmer Biomet Holdings, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/3x0btk
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
View original content:https://www.prnewswire.com/news-releases/global-autologous-matrix-induced-chondrogenesis-amic-strategic-industry-report-2022-2024-and-2030---us-market-is-estimated-at-49-5-million-while-china-is-forecast-to-grow-at-9-8-cagr-302072986.html
SOURCE Research and Markets
|
|
|
|
|
 |
Weekly Recap: 11 Tech Press Releases You Need to See | Jan 22, 2026
|
|
Sup AI Sets New Benchmark Record with 52.15% on Humanity's Last Exam | Jan 22, 2026
|
|
DEADLINE ANNOUNCED FOR 2026 NEW TOP-LEVEL DOMAIN APPLICATIONS | Jan 22, 2026
|
|
Trigent Partners with WeWork India to Expand its GCC Footprint | Jan 22, 2026
|
|
Skunk Works® and XTEND Expand Joint All Domain Command and Control for Advanced Mission Execution | Jan 22, 2026
|
|
Exia Labs Brings Keystone to the U.S. Navy via DIU's Blue Object Management Challenge | Jan 22, 2026
|
|
Altair HyperWorks 2026 Delivers Design and Simulation at Scale with AI | Jan 22, 2026
|
|
Glasswall Brings Defense-Level File Sanitization to Every Government Agency and Business Using Microsoft 365 | Jan 22, 2026
|
|
The Roadmap to Securing Your Own Digital Domain is Now Available | Jan 22, 2026
|
|
Buyers Edge Platform Appoints Jaime Selga to Lead Expansion Across the Middle East, Africa & Asia | Jan 22, 2026
|
|
|
